Insights

Strategic Growth Seminis operates within the biotechnology seed sector with a revenue range of 100–250 million and substantial funding, indicating growing opportunities for strategic partnerships, co-development, and distribution deals with large agri-biotech players.

Industry Positioning As a seed company now part of Bayer’s portfolio, Seminis benefits from strong corporate backing and access to extensive global distribution networks, presenting a ready-made channel for tiered sales, cross-sell of seed traits, and expanded product lines.

Campaign Engagement Recent activity launching campaigns like Seasoned Vegetables at ASTA suggests opportunities to collaborate on marketing campaigns, genetic trait showcases, and grower education programs that can drive demand for new hybrids and home garden varieties.

Product Innovation Historically, Seminis has introduced distinctive varieties (purple tomato hybrid for home gardeners, new cantaloupe, thick-walled peppers) signaling strong R&D output; sales opportunities include licensing, co-branding, and trials of innovative cultivars with retail and professional growers.

Channel Expansion With a mid-size employee base and alignment with Bayer, there is potential to expand through strategic partnerships with distributors and seed channels in both traditional agriculture and home gardening segments, leveraging Bayer’s ecosystem for market access and scale.

Similar companies to Seminis

Seminis Tech Stack

Seminis uses 8 technology products and services including Webtrends, Adobe Experience Manager, Microsoft SharePoint, and more. Explore Seminis's tech stack below.

  • Webtrends
    Analytics
  • Content Management System
  • Content Management System
  • Google Fonts API
    Font Scripts
  • jQuery
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • Java
    Programming Languages
  • Microsoft ASP.NET
    Web Frameworks

Seminis's Email Address Formats

Seminis uses at least 4 email formats:
Seminis Email FormatsExamplePercentage
First.Last@seminis.comJohn.Doe@seminis.com
97%
Last.First@seminis.comDoe.John@seminis.com
1%
First.Middle@seminis.comJohn.Michael@seminis.com
1%
First.L@seminis.comJohn.D@seminis.com
1%

Frequently Asked Questions

What is Seminis's stock symbol?

Minus sign iconPlus sign icon
Seminis is a publicly traded company; the company's stock symbol is SMNS.

What is Seminis's official website and social media links?

Minus sign iconPlus sign icon
Seminis's official website is seminis.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Seminis generate?

Minus sign iconPlus sign icon
As of August 2026, Seminis's annual revenue is estimated to be $100M - $250M.

What is Seminis's SIC code and NAICS code?

Minus sign iconPlus sign icon
Seminis's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Seminis have currently?

Minus sign iconPlus sign icon
As of August 2026, Seminis has approximately 132 employees across 5 continents, including North America, Asia and South America. Key team members include Chief Executive Officer: T. J., Chief Executive Officer: T. N. and Mdo: A. D. Explore Seminis's employee directory with LeadIQ.

What industry does Seminis belong to?

Minus sign iconPlus sign icon
Seminis operates in the Biotechnology Research industry.

What technology does Seminis use?

Minus sign iconPlus sign icon
Seminis's tech stack includes Webtrends, Adobe Experience Manager, Microsoft SharePoint, Google Fonts API, jQuery, Underscore.js, Java and Microsoft ASP.NET.

What is Seminis's email format?

Minus sign iconPlus sign icon
Seminis's email format typically follows the pattern of First.Last@seminis.com. Find more Seminis email formats with LeadIQ.

How much funding has Seminis raised to date?

Minus sign iconPlus sign icon
As of August 2026, Seminis has raised $222M in funding. The last funding round occurred on Jun 03, 2003 for $222M.
Seminis logo

Seminis

Biotechnology ResearchUnited States51-200 Employees

Seminis is a United States–based company operating in the biotechnology research sector, specializing in vegetable seeds. It develops and markets seed varieties for growers, collaborating with industry partners to bring new products to market. The firm’s product history includes the Don David cantaloupe variety launched in 2016 and a purple tomato hybrid released for home gardeners in 2019.
In 2018, Seminis became part of Bayer AG when Bayer acquired Monsanto Co. In February 2026, the company participated in the American Seed Trade Association event in San Diego, California, where it introduced the Seasoned Vegetables Campaign to growers and industry partners and previewed the campaign video and initial products. Positioned within the seed and plant biotechnology arena, Seminis serves growers and industry partners with vegetable seed varieties and related products.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
SMNS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $222M

    Seminis has raised a total of $222M of funding over 1 rounds. Their latest funding round was raised on Jun 03, 2003 in the amount of $222M as a Private Equity.

  • $100M - $250M

    Seminis's revenue is estimated to be in the range of $100M - $250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.